Hillsdale Investment Management’s Protolabs PRLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Buy
191,594
+17,210
+10% +$1.21M 0.36% 52
2026
Q1
$9.94M Buy
174,384
+6,100
+4% +$354K 0.27% 57
2025
Q4
$8.51M Sell
168,284
-1,300
-0.8% -$66.5K 0.23% 78
2025
Q3
$8.48M Buy
169,584
+15,960
+10% +$731K 0.26% 69
2025
Q2
$6.15M Buy
153,624
+34,000
+28% +$1.27M 0.23% 98
2025
Q1
$4.19M Buy
119,624
+3,900
+3% +$154K 0.21% 94
2024
Q4
$4.52M Buy
115,724
+900
+0.8% +$32.3K 0.23% 101
2024
Q3
$3.37M Buy
114,824
+230
+0.2% +$7.02K 0.26% 158
2024
Q2
$3.54M Sell
114,594
-3,500
-3% -$111K 0.28% 142
2024
Q1
$4.22M Buy
118,094
+17,720
+18% +$640K 0.33% 112
2023
Q4
$3.91M Buy
+100,374
New +$3.25M 0.32% 119
2014
Q1
Sell
-800
Closed -$57K 571
2013
Q4
$57K Buy
+800
New +$62K 0.02% 429

Other funds holding PRLB

Hillsdale Investment Management's PRLB Position: Q2 2026 in Review

Hillsdale Investment Management increased its Protolabs (PRLB) stake by 9.9% in Q2 2026, buying an estimated $1.21M and bringing the position to 191,594 shares worth $15.6M. The position accounts for 0.36% of the portfolio, ranked #52.

Hillsdale Investment Management first reported a position in PRLB in Q4 2013 and has held it in 12 quarters since. 278 funds tracked by Wall St. Rank hold PRLB as of Q2 2026.

  • Hillsdale Investment Management held 191,594 shares of Protolabs worth $15.6M as of Q2 2026.
  • Hillsdale Investment Management bought 17,210 Protolabs shares in Q2 2026, an estimated $1.21M.
  • Protolabs made up 0.36% of Hillsdale Investment Management's portfolio in Q2 2026, its #52 holding.
  • Hillsdale Investment Management first reported a position in Protolabs in Q4 2013 and has held it in 12 quarters since.
  • 278 funds tracked by Wall St. Rank held Protolabs as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.